PuSH - Publication Server of Helmholtz Zentrum München

Veith, V.* ; Pedersen, F.* ; Groth, E.E.* ; Watz, H.* ; Maison, N. ; Schaub, B.* ; von Mutius, E.* ; Hansen, G.* ; Dittrich, A.M.* ; Brinkmann, F.* ; Kopp, M.* ; Bahmer, T.* ; Waschki, B.* ; Rabe, K.F.* ; Abdo, M.*

Frequency and clinical relevance of residual bronchodilator responsiveness in adults with asthma.

J. Allergy Clin. Immunol. Pract., DOI: 10.1016/j.jaip.2026.07.012 (2026)
Postprint DOI PMC
Open Access Green
Background: Bronchodilator responsiveness (BDR) reflects airflow variability in asthma and is typically assessed after withholding therapy. However, its relevance under ongoing maintenance therapy remains unclear. Objective: To investigate the frequency and clinical relevance of residual bronchodilator responsiveness (rBDR) in patients with asthma receiving maintenance therapy. Methods: In 248 adults with moderate-to-severe asthma receiving inhaled corticosteroids, with or without long-acting bronchodilators, rBDR was assessed according to European Respiratory Society / American Thoracic Society 2005 and 2022 criteria. Maintenance therapy was continued, while short-acting bronchodilators were withheld for at least 12 hours before spirometry. Type 2 biomarkers, lung function including small airway function, patient-reported outcomes, and exacerbation rates were analyzed according to rBDR status. Results: rBDR was present in approximately 23% of patients and was consistent across both European Respiratory Society / American Thoracic Society criteria. Maintenance therapy did not differ by rBDR status. Patients with rBDR had higher type 2 biomarkers, despite high-dose inhaled corticosteroid, including sputum eosinophils and fractional exhaled nitric oxide, more frequent fixed airflow obstruction, and greater small airway dysfunction. They also exhibited increased clinical disease burden, with poorer asthma control and frequent exacerbations, independent of underlying lung function and type 2 inflammation. Conclusions: rBDR is frequent and identifies patients with refractory type 2 inflammation and poor disease control. rBDR integrates inflammatory activity and functional impairment into a simple, widely available measure and may serve as a practical marker to identify residual disease burden and guide treatment optimization in routine clinical care.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Keywords Airway Obstruction ; Asthma ; Bronchodilator Responsiveness ; Ers/ats Criteria ; Lung Function Variability ; Small Airway Disease ; Spirometry ; Type 2 Inflammation
ISSN (print) / ISBN 2213-2198
e-ISSN 2213-2201
Journal The journal of allergy and clinical immunology. In practice
Publisher Elsevier
Publishing Place Amsterdam [u.a.]
Reviewing status Peer reviewed
Institute(s) Institute for Asthma and Allergy Prevention (IAP)